J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M800031-JLR200 on March 14, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M800031-JLR200v1
49/7/1488    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Boesze-Battaglia, K.
Right arrow Articles by Fliesler, S. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boesze-Battaglia, K.
Right arrow Articles by Fliesler, S. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 1488-1499, July 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome*

Kathleen Boesze-Battaglia*, Monika Damek-Poprawa*, Drake C. Mitchell{dagger}, Laura Greeley{dagger}, Richard S. Brush§,{dagger}{dagger}, Robert E. Anderson§,**,{dagger}{dagger}, Michael J. Richards§§ and Steven J. Fliesler1,§§,***

* From the Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104
{dagger} the Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892
§ the Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104
** the Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104
{dagger}{dagger} Dean McGee Eye Institute, Oklahoma City, OK 73104
§§ the Department of Ophthalmology (Saint Louis University Eye Institute), Saint Louis University School of Medicine, St. Louis, MO 63104
*** the Department of Pharmacological & Physiological Science, Saint Louis University School of Medicine, St. Louis, MO 63104

* This study was supported by United States Public Health System, National Institutes of Health Grants EY-007361 (S.J.F.), EY-00871 (R.E.A.), EY-04149 (R.E.A.), EY-10420 (K.B-B.), EY-12190 (R.E.A.), and RR-17703 (R.E.A); the Foundation Fighting Blindness (R.E.A.); and unrestricted departmental grants from Research to Prevent Blindness (S.J.F. and R.E.A.). K.B-B. is the recipient of an E. Matilda Ziegler Vision Award. S.J.F. is the recipient of a Research to Prevent Blindness Senior Scientific Investigator Award.

Published, JLR Papers in Press, March 14, 2008.

1 To whom correspondence should be addressed. e-mail: fliesler{at}slu.edu

Smith-Lemli-Opitz syndrome (SLOS) is caused by an inherited defect in the last step in cholesterol (Chol) biosynthesis, leading to abnormal accumulation of 7-dehydrocholesterol and decreased Chol levels. Progressive retinal degeneration occurs in an animal model of SLOS, induced by treating rats with AY9944, a selective inhibitor of the enzyme affected in SLOS. Here we evaluated alterations in the biochemical and physical properties of retinal rod outer segment (ROS) membranes in this animal model. At 1 month of AY9944 treatment, there were modest alterations in fatty acid composition, but no significant differences in cis-parinaric acid (cPA) spectroscopic parameters in ROS membranes from treated versus control rats. However, at 3 months, ROS docosahexaenoic acid (DHA) content was dramatically reduced, and cPA fluorescence anisotropy values were decreased, relative to controls. Also, 1,6-diphenyl-1,3,5-hexatriene exhibited decreased rotational motion and increased orientational order in ROS membranes from 3 month-old AY9944-treated rats, relative to controls. No significant changes in protein:lipid ratios were observed; however, rhodopsin regenerability was compromised by 3 months of treatment. These findings are consistent with reduced ROS membrane fluidity in the SLOS rat model, relative to controls, primarily due to the dramatic reduction in membrane DHA levels, rather than altered sterol composition.

Supplementary key words fluorescence polarization • cis-parinaric acid • diphenylhexatriene • fatty acid • retina • AY9944

Abbreviations: 7DHC, 7-dehydrochosterol; BRD, Brownian rotational diffusion; Chol, cholesterol; cPA, cis-parinaric acid; DHA, docosahexaenoic acid; DPH, 1,6-diphenyl-1,3,5-hexatriene; mAb, monoclonal antibody; ROS, rod outer segment; SLOS, Smith-Lemli-Opitz syndrome


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.